Your account is not claimed yet. You can sign up with ORCID to claim your account.

Tony S K Mok (Tony Sk Mok, Tony S Mok, Tony Mok)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 10

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Future oncology (London, England)

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Antonio Passaro, Julie Brahmer, Scott Antonia, Tony S K Mok, Solange Peters
Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel Strategies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (6) (2022)
Gilberto de Castro Junior, Iveta Kudaba, Yi-Long Wu, Gilberto de Lima Lopes, Dariusz Mirosław Kowalski, Hande Z Turna, Christian Caglevic, Li Zhang, Boguslawa Karaszewska, Konstantin K Laktionov, Vichien Srimuninnimit, Igor Bondarenko, Kaoru Kubota, Rinee Mukherjee, Jianxin Lin, Fabricio Souza, Tony S K Mok, Byoung Chul Cho
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non-Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Benjamin J Solomon, Todd M Bauer, Sai-Hong Ignatius Ou, Geoffrey Liu, Hidetoshi Hayashi, Alessandra Bearz, Konstantin Penkov, Yi-Long Wu, Oscar Arrieta, Jacek Jassem, Anna M Calella, Gerson Peltz, Anna Polli, Holger Thurm, Tony S K Mok
Post Hoc Analysis of Lorlatinib Intracranial Efficacy and Safety in Patients With ALK -Positive Advanced Non-Small-Cell Lung Cancer From the Phase III CROWN Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (31) (2022)
Jay M Lee, Masahiro Tsuboi, Edward S Kim, Tony S K Mok, Pilar Garrido Lopez
Overcoming immunosuppression and pro-tumor inflammation in lung cancer with combined IL-1β and PD-1 inhibition. Future oncology (London, England) 18 (27) (2022)
Melissa Lynne Johnson, Byoung Chul Cho, Alexander Luft, Jorge Alatorre-Alexander, Sarayut Lucien Geater, Konstantin Laktionov, Sang-We Kim, Grygorii Ursol, Maen Hussein, Farah Louise Lim, Cheng-Ta Yang, Luiz Henrique Araujo, Haruhiro Saito, Niels Reinmuth, Xiaojin Shi, Lynne Poole, Solange Peters, Edward B Garon, Tony S K Mok, null null
Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Jesus Corral, Tony S K Mok, Yi-Long Wu
Withdrawal of dacomitinib treatment due to absence of toxicities is not justified. Future oncology (London, England) (2022)
Molly Li, Kevin Mok, Tony S K Mok
A Detouring Experience Not Recommended: Lessons Learned from PF00299804. Cancer research 82 (20) (2022)
Sehhoon Park, Chan-Young Ock, Hyojin Kim, Sergio Pereira, Seonwook Park, Minuk Ma, Sangjoon Choi, Seokhwi Kim, Seunghwan Shin, Brian Jaehong Aum, Kyunghyun Paeng, Donggeun Yoo, Hongui Cha, Sunyoung Park, Koung Jin Suh, Hyun Ae Jung, Se Hyun Kim, Yu Jung Kim, Jong-Mu Sun, Jin-Haeng Chung, Jin Seok Ahn, Myung-Ju Ahn, Jong Seok Lee, Keunchil Park, Sang Yong Song, Yung-Jue Bang, Yoon-La Choi, Tony S K Mok, Se-Hoon Lee
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (17) (2022)
Pilar Garrido Lopez, Jean-Louis Pujol, Edward S Kim, Jay M Lee, Masahiro Tsuboi, Ana Gómez-Rueda, Amparo Benito, Nicolas Moreno, Luis Gorospe, Tuochuan Dong, Cecile Blin, Vanessa Rodrik-Outmezguine, Vanessa Q Passos, Tony S K Mok
Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study design. Future oncology (London, England) 17 (12) (2021)
Jean Paty, Rickard Sandin, Arlene Reisman, Yi-Long Wu, Maria Rita Migliorino, Xiangdong Zhou, Ying Cheng, Ki Hyeong Lee, Kazuhiko Nakagawa, Seiji Niho, Jesús Corral, Adam Płużański, Rolf Linke, Oren Meyers, Tony S K Mok
The patient's perspective on treatment with dacomitinib: patient-reported outcomes from the Phase III trial ARCHER 1050. Future oncology (London, England) 17 (7) (2020)

Tony S K Mok.css-eqlu8i{font-size:small;padding-left:4px;} (Tony Sk Mok, Tony S Mok, Tony Mok)

Publication Activity (10 Years)

Top Topics

Top Venues

Tony S K Mok (Tony Sk Mok, Tony S Mok, Tony Mok)